Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2022 | Potential of iPSC models in Alzheimer’s disease research

Anne Hedegaard • 2 Mar 2022
ARUK 2022
Alzheimer’s Disease Dementia

Anne Hedegaard, PhD, Univeristy of Oxford, Oxford, UK, discusses the advantages of using induced pluripotent stem cell (iPSC) models in Alzheimer’s disease research. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.

More from Anne Hedegaard

1:41
Using a human cellular model to investigate inflammatory crosstalk in Alzheimer's disease
Anne Hedegaard • 2 Mar 2022
1:10
Underlying causes of chronic inflammation in Alzheimer’s disease
Anne Hedegaard • 2 Mar 2022

Related Videos

2:33
Anti-amyloid therapy for Alzheimer's disease: beyond the 18-month mark
Dorota Religa • 22 Mar 2024
0:50
Will long-term anti-amyloid treatment show greater clinical benefit?
Dorota Religa • 22 Mar 2024
1:24
Digital frailty screening in dementia
Dorota Religa • 22 Mar 2024
4:19
Current projects from Alzheimer’s Disease International
Paola Barbarino • 23 Mar 2024
The content of VJDementia is intended for healthcare professionals